Related Experiment Video
Updated: May 14, 2026

Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis
Published on: March 31, 2015
Ectopic expression of Zmiz1 induces cutaneous squamous cell malignancies in a mouse model of cancer
Laura M Rogers1, Jesse D Riordan, Brian L Swick
1Department of Anatomy and Cell Biology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa 52242, USA.
Abstract:
Cutaneous squamous cell carcinoma (SCC) is the second most common form of cancer in the human population, yet the underlying genetic mechanisms contributing to the disease are not well understood. We recently identified Zmiz1 as a candidate oncogene in nonmelanoma skin cancer through a transposon mutagenesis screen. Here we show that transposon-induced mutations in Zmiz1 drive expression of a truncated transcript that is similar to an alternative endogenous ZMIZ1 transcript found to be overexpressed in human SCCs relative to normal skin. We also describe an original mouse model of invasive keratoacanthoma driven by skin-specific expression of the truncated Zmiz1 transcript. Unlike most mouse models, Zmiz1-induced skin tumors develop rapidly and in the absence of promoting agents such as phorbol esters. In addition, we found that the alternative Zmiz1 isoform has greater protein stability than its full-length counterpart. Finally, we provide evidence that ZMIZ1 is overexpressed in a significant percentage of human breast, ovarian, and colon cancers in addition to human SCCs, suggesting that ZMIZ1 may play a broader role in epithelial cancers.
Insights
A truncated Zmiz1 transcript drives skin cancer development and is overexpressed in various human cancers, suggesting ZMIZ1’s broader oncogenic role in epithelial cancers.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cutaneous squamous cell carcinoma (SCC) is a prevalent cancer with poorly understood genetic drivers.
- Zmiz1 was identified as a potential oncogene in nonmelanoma skin cancer via mutagenesis screening.
Purpose of the Study:
- To investigate the role of Zmiz1 in skin cancer development.
- To characterize a novel mouse model for invasive keratoacanthoma.
- To explore ZMIZ1's potential role in other epithelial cancers.
Main Methods:
- Transposon mutagenesis screen to identify candidate oncogenes.
- Analysis of Zmiz1 transcript variants in human SCCs.
- Development of a skin-specific mouse model expressing a truncated Zmiz1 transcript.
- Protein stability assays.
- Analysis of ZMIZ1 expression in human breast, ovarian, and colon cancers.
Main Results:
- Mutations in Zmiz1 lead to a truncated transcript similar to an overexpressed endogenous isoform in human SCCs.
- A novel mouse model rapidly develops invasive keratoacanthoma upon skin-specific expression of the truncated Zmiz1.
- The alternative Zmiz1 isoform exhibits enhanced protein stability compared to the full-length version.
- ZMIZ1 is overexpressed in human breast, ovarian, and colon cancers, in addition to SCCs.
Conclusions:
- A truncated Zmiz1 transcript contributes to skin cancer initiation and progression.
- Zmiz1 plays a significant role in the pathogenesis of invasive keratoacanthoma.
- ZMIZ1 may function as a broader oncogene in multiple types of epithelial cancers.
Related Concept Videos
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Induced Pluripotent Stem Cells
Somatic cells are...

